The concentration of ganciclovir eye drops for hospital preparation was changed from 0.5％ to 2.0％ at the Nagasaki University Hospital from March 2015. We investigated the incidence of side eŠects in 12 patients using 2.0％ ganciclovir eye drops and evaluated the cytotoxicity of 2.0％ ganciclovir eye drops using cultured rabbit corneal cells in vitro. As a side eŠect of 2.0％ ganciclovir eye drops, three patients exhibited an early feeling of transient stimulation. The 2.0％ ganciclovir eye drops did not demonstrate cell cytotoxicity for cultured corneal cells after 5 min, but did after 10 min. Theseˆndings suggested that the 2.0％ ganciclovir eye drops can be used without corneal epithelium disorder in clinical settings. 

